Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.
Journal: Journal of clinical immunology
Published: March 16, 2023
Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: June 03, 2014
Chapter 4: Stinging insect allergy and venom immunotherapy.
Journal: Allergy and asthma proceedings
Published: July 17, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026